摘要
目的了解磺脲类药物受体(SUR)基因与中国人非胰岛素依赖型糖尿病(NIDDM)的相关关系。方法采用多聚酶链式反应限制性酶切片段长度多态性分析技术(PCRRFLP),对位于SUR基因第22外显子及第24内含子的多态性位点同中国人NIDDM的相关性进行了分子遗传学研究。结果SUR基因第24内含子的“c”等位基因频率在中国人NIDDM人群中显著增高(68%比55%,P=0007),且“cc”纯合子基因型的频率亦在NIDDM人群中显著增高(419%比277%,P=0013,OR=439,CI:15~127)。结论SUR基因的多态性与不同人种的NIDDM具有相关性。
Objective To test the role of Sulfonylurea receptor gene(SUR) in the pathogenesis of NIDDM in Chinese population Methods We studied the polymorphisms of the SUR gene in intron 24 and exon 22 by polymerase chain reaction(PCR) and appropriate restriction enzyme (PCR RFLP) in 86 NIDDM patients with at least two first degree diabetic relatives and 148 normal control subjects. Results The frequency of “c” allele of intron 24 in NIDDM patients was significantly increased as compared with that in the control subjects (68 02%vs. 55 41, P =0.007), and the frequency of the “cc” genotype of intron 24 in the NIDDM group was also significantly higher than that in the control group (41.86% vs. 27.7%, P =0.013 ,OR=4. 39, CI: 1.52 12.66). The polymorphism of exon 22 described in the Caucasian population was not detected Conclusion The association of the polymorphism of SUR gene with NIDDM in different races suggests that the SUR gene or nearby gene may play an important role in the genetic susceptibility of NIDDM.
出处
《中华医学杂志》
CAS
CSCD
北大核心
1998年第10期774-775,共2页
National Medical Journal of China
关键词
糖尿病
NIDDM
基因多态性
磺脲类药
Diabetes mellitus, Non insulin dependent Gene Receptors, drug